Showing Results for
- Academic Journals (172)
Search Results
- 172
Academic Journals
- 172
- Search Terms:
- 1From: Immunotherapy. (Vol. 3, Issue 4) Peer-ReviewedAdoptive transfer of T cells remains a promising approach in melanoma. Initial clinical trials performed with polyclonal tumor-infiltrating lymphocyte gave limited clinical results. Nonetheless, encouraging results have...
- 2From: Immunotherapy. (Vol. 3, Issue 3) Peer-ReviewedTargeting of radionuclides with antibodies, or radioimmunotherapy, has been an active field of research spanning nearly 50 years, evolving with advancing technologies in molecular biology and chemistry, and with many...
- 3From: Immunotherapy. (Vol. 3, Issue 6) Peer-ReviewedEvaluation of: Lin Y, Gustafson MP, Bulur PA, Gastineau DA, Witzig TE, Dietz AB: Immunosuppressive CD14.sup.+ HLA-DR.sup.low/- monocytes in B-cell non-Hodgkin'âs lymphoma. Blood 117, 872-881 (2011). The mechanisms of...
- 4From: Immunotherapy. (Vol. 3, Issue 8) Peer-ReviewedCryptococcus neoformans is an opportunistic fungal pathogen responsible for life-threatening infections in immunocompromised individuals and occasionally in those with no known immune impairment. The fungus is endowed...
- 5From: Immunotherapy. (Vol. 3, Issue 4s) Peer-ReviewedOrgan transplantation is currently the only effective treatment for end-stage organ failure. However, success is limited by the immune response of the recipient to allogeneic tissues (recognized by the direct and...
- 6From: Immunotherapy. (Vol. 3, Issue 12) Peer-ReviewedSirolimus (SRL) is a mammalian target of rapamycin inhibitor, which provides an immunosuppressive effect by inhibiting cell cycle progression. The encouraging results of combined SRL-cyclosporine therapy paved the way to...
- 7From: Immunotherapy. (Vol. 3, Issue 12) Peer-ReviewedAuthor(s): Mansour Mohamadzadeh [**] 1 , Jennifer L Owen 2 KEYWORDS : dendritic cells; inflammation; intestinal bowel diseases; Lactobacillus acidophilus Intestinal inflammation is a complex immunologic...
- 8From: Immunotherapy. (Vol. 3, Issue 4) Peer-ReviewedResearchers at Emory Vaccine Center (GA, USA) have recently demonstrated that nanoparticles designed to resemble viruses and mimic the immunostimulating effect of the yellow fever vaccine (YF-17D) are able to include...
- 9From: Immunotherapy. (Vol. 3, Issue 4) Peer-ReviewedAuthor(s): Lindzy F Dodson [[dagger]] 2 , William G Hawkins 1 , Peter Goedegebuure 1 KEYWORDS : chimeric antigen receptor; immune suppression; immune therapy; MDSC; pancreatic cancer; T cell; Treg; vaccine...
- 10From: Immunotherapy. (Vol. 3, Issue 6) Peer-ReviewedAuthor(s): Amy Hall 1 The meeting was opened by the chair, Marc Veldhoen (Babraham Institute, Cambridge, UK) (Figure 1), with an introduction of the six major subpopulations of CD4+ T helper (Th) cells in the immune...
- 11From: Immunotherapy. (Vol. 3, Issue 1) Peer-ReviewedAuthor(s): Lesley Margaret Chiverton 1 'Why are we interested in scale-down?' was the question posed by Gary Lye (University College London, UK), the Chair at the opening of the meeting. Lye then went on to suggest...
- 12From: Immunotherapy. (Vol. 3, Issue 3) Peer-ReviewedAuthor(s): Dimitris I Mitsias 1 , Savvas Savvatianos 1 , Nikolaos G Papadopoulos [[dagger]] 2 KEYWORDS : allergen-specific immunotherapy; apoptosis; desensitization; IDO; indoleamine 2,3-dioxygenase; inhibitory...
- 13From: Immunotherapy. (Vol. 3, Issue 11) Peer-ReviewedAuthor(s): Clémentine Perrier 1 , Paul Rutgeerts [[dagger]] 2 KEYWORDS : anti-TNF therapy; cytokines; IFN-γγ; IL-6; IL-10; IL-11; IL-12; IL-17; inflammatory bowel disease Inflammatory bowel diseases...
- 14From: Immunotherapy. (Vol. 3, Issue 8) Peer-ReviewedAuthor(s): Ewa Cichocka-Jarosz 1 , Agnieszka Dorynska 2 , Jacek J Pietrzyk 1 , Radoslaw Spiewak [[dagger]] 2 KEYWORDS : allergy; basophil activation; children; honeybee venom; immunotherapy; mast-cell...
- 15From: Immunotherapy. (Vol. 3, Issue 7) Peer-ReviewedAuthor(s): Stephan Deifl 1 , Barbara Bohle [[dagger]] 2 KEYWORDS : adjuvants; allergen; allergenicity; allergen-specific immunotherapy; allergy; vaccine design This article will address two 'hot topics'â in...
- 16From: Immunotherapy. (Vol. 3, Issue 9) Peer-ReviewedAuthor(s): Nelianne J Verkaik [[dagger]] 3 , Willem JB van Wamel 1 , Alex van Belkum 1 2 KEYWORDS : antibodies; capsular polysaccharide; colonization; immunization; immunotherapy; infection; MSCRAMM;...
- 17From: Immunotherapy. (Vol. 3, Issue 2) Peer-ReviewedAuthor(s): David WC Beasley 1 KEYWORDS : monoclonal antibodies; passive immunization; vaccine; West Nile virus In 1999, West Nile virus (WNV) was identified as the cause of an outbreak of neurological...
- 18From: Immunotherapy. (Vol. 3, Issue 12) Peer-ReviewedAuthor(s): Ronald Charles 1 , Lina Lu 1 2 , Shiguang Qian 1 2 , John J Fung [**] 3 KEYWORDS : allogeneic; hepatic stellate cell; immunosuppression; mesenchymal stem cell; Sertoli cells; tolerance The immune...
- 19From: Immunotherapy. (Vol. 3, Issue 4s) Peer-ReviewedAuthor(s): Delphine Michel-Monigadon 1 , Philippe Brachet 1 , Isabelle Neveu 1 , Philippe Naveilhan [[dagger]] 2 KEYWORDS : immunosuppression; neural stem cells; neurodegenerative diseases; neurotrophic...
- 20From: Immunotherapy. (Vol. 3, Issue 11) Peer-ReviewedAuthor(s): Melissa G Lechner 1 , Sarah M Russell 1 , Rikki S Bass 1 , Alan L Epstein [[dagger]] 1 KEYWORDS : chemokines; costimulatory molecules; fusion proteins; immunotherapy; regulatory T cells; tumor...